{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T15:59:37Z","timestamp":1789747177388,"version":"4.0.1"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,9,17]],"date-time":"2020-09-17T00:00:00Z","timestamp":1600300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,9,17]],"date-time":"2020-09-17T00:00:00Z","timestamp":1600300800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"crossref","award":["File no.5\/8\/7\/15\/2010\/ECD-I"],"award-info":[{"award-number":["File no.5\/8\/7\/15\/2010\/ECD-I"]}],"id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Kyasanur Forest disease (KFD) is a tick-borne, acute, febrile viral illness endemic in southern India. No major studies have been done to understand the adaptive immune response during KFDV infection in humans. In this study, KFDV-positive patients were prospectively enrolled, and repeated peripheral blood collections were performed. Clinical and virologic characterization of these samples is reported along with phenotypic analysis of cellular immunity and quantitation of humoral immunity. We noted robust T and B cell responses, particularly of CD8 T cells, during KFDV infection in most of the patients. Virus clearance from the blood coincided with peak CD8 T cell activation and the appearance of KFDV-specific IgG. Increased frequency of plasmablasts and very few activated B cells were observed in the acute phase of KFD infection. Notably, only humoral immunity and activated B cell frequency in the acute phase correlated with prior KFDV vaccination, and only with 2 or more doses. This novel work has implications in KFD vaccine research as well as in understanding the pathogenesis.<\/jats:p>","DOI":"10.1038\/s41598-020-72205-1","type":"journal-article","created":{"date-parts":[[2020,9,17]],"date-time":"2020-09-17T21:28:45Z","timestamp":1600378125000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Dynamics of human B and T cell adaptive immune responses to Kyasanur Forest disease virus infection"],"prefix":"10.1038","volume":"10","author":[{"given":"Santhosha","family":"Devadiga","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anita K.","family":"McElroy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suresha G.","family":"Prabhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Govindakarnavar","family":"Arunkumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,9,17]]},"reference":[{"key":"72205_CR1","first-page":"111","volume":"31","author":"TH Work","year":"1958","unstructured":"Work, T. H. Virological aspects of Kyasanur Forest disease. J. Indian Med. Assoc. 31, 111\u2013113 (1958).","journal-title":"J. Indian Med. Assoc."},{"key":"72205_CR2","volume-title":"Kyasanur Forest Disease: a public health concern","author":"CD Alert","year":"2018","unstructured":"Alert, C. D. Kyasanur Forest Disease: a public health concern (National Center for Disease Control, Directorate General of Health Services, Delhi, 2018)."},{"key":"72205_CR3","doi-asserted-by":"publisher","first-page":"145","DOI":"10.4103\/ijmr.IJMR_688_17","volume":"148","author":"A Munivenkatappa","year":"2018","unstructured":"Munivenkatappa, A., Sahay, R., Yadav, P., Viswanathan, R. & Mourya, D. Clinical & epidemiological significance of Kyasanur forest disease. Indian J. Med. Res. 148, 145 (2018).","journal-title":"Indian J. Med. Res."},{"key":"72205_CR4","unstructured":"Centers for Disease Control and Prevention. Kyasanur Forest Disease (KFD). Available at: https:\/\/www.cdc.gov\/vhf\/kyasanur\/index.html. (Accessed: 21st June 2019)"},{"key":"72205_CR5","first-page":"113","volume":"31","author":"RL Rao","year":"1958","unstructured":"Rao, R. L. Clinical observations on Kyasanur Forest disease cases. J. Indian Med. Assoc. 31, 113\u2013116 (1958).","journal-title":"J. Indian Med. Assoc."},{"key":"72205_CR6","doi-asserted-by":"publisher","first-page":"S854","DOI":"10.1093\/clinids\/11.Supplement_4.S854","volume":"11","author":"K Pavri","year":"1989","unstructured":"Pavri, K. Clinical, clinicopathologic, and hematologic features of Kyasanur Forest disease. Rev. Infect. Dis. 11, S854\u2013S859 (1989).","journal-title":"Rev. Infect. Dis."},{"key":"72205_CR7","doi-asserted-by":"publisher","first-page":"278","DOI":"10.3201\/eid1902.120544","volume":"19","author":"GS Kasabi","year":"2013","unstructured":"Kasabi, G. S. et al. Kyasanur Forest disease, India, 2011\u20132012. Emerg. Infect. Dis. 19, 278\u2013281 (2013).","journal-title":"Emerg. Infect. Dis."},{"key":"72205_CR8","doi-asserted-by":"publisher","first-page":"2005","DOI":"10.1371\/journal.pntd.0002025","volume":"7","author":"GS Kasabi","year":"2013","unstructured":"Kasabi, G. S. et al. Coverage and effectiveness of Kyasanur Forest disease (KFD) vaccine in Karnataka, South India, 2005\u20132010. PLoS Negl. Trop. Dis. 7, 2005\u20132015 (2013).","journal-title":"PLoS Negl. Trop. Dis."},{"key":"72205_CR9","first-page":"199","volume":"93","author":"PS Sathe","year":"1991","unstructured":"Sathe, P. S., Dandawate, C. N., Sharadamma, K. & Ghosh, S. N. Circulating interferon-alpha in patients with Kyasanur forest disease. Indian J. Med. Res. 93, 199\u2013201 (1991).","journal-title":"Indian J. Med. Res."},{"key":"72205_CR10","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1371\/journal.pntd.0002934","volume":"8","author":"B Sawatsky","year":"2014","unstructured":"Sawatsky, B., McAuley, A. J., Holbrook, M. R. & Bente, D. A. Comparative pathogenesis of Alkhumra hemorrhagic fever and Kyasanur Forest disease viruses in a mouse model. PLoS Negl. Trop. Dis. 8, 2 (2014).","journal-title":"PLoS Negl. Trop. Dis."},{"key":"72205_CR11","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1086\/514321","volume":"179","author":"TG Ksiazek","year":"1999","unstructured":"Ksiazek, T. G. et al. CJP clinical virology of ebola hemorrhagic fever (EHF): Virus, virus antigen, and IgG and IgM antibody findings among EHF patients in Kikwit, Democratic Republic of the Congo, 1995. J. Infect. Dis. 179, 177\u2013187 (1999).","journal-title":"J. Infect. Dis."},{"key":"72205_CR12","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.jviromet.2012.07.019","volume":"186","author":"DT Mourya","year":"2012","unstructured":"Mourya, D. T. et al. Diagnosis of Kyasanur forest disease by nested RT-PCR, real-time RT-PCR and IgM capture ELISA. J. Virol. Methods 186, 49\u201354 (2012).","journal-title":"J. Virol. Methods"},{"key":"72205_CR13","unstructured":"Arunkumar G. Annual review of Hospital based surveillance of Acute Febrile Illness in India. (2017)."},{"key":"72205_CR14","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciz010","author":"G Arunkumar","year":"2019","unstructured":"Arunkumar, G. et al. Adaptive immune responses in humans during Nipah virus acute and convalescent phases of infection. Clin. Infect. Dis. https:\/\/doi.org\/10.1093\/cid\/ciz010 (2019).","journal-title":"Clin. Infect. Dis."},{"key":"72205_CR15","doi-asserted-by":"publisher","first-page":"1862","DOI":"10.1093\/infdis\/jix201","volume":"215","author":"AK Mcelroy","year":"2017","unstructured":"Mcelroy, A. K. et al. A case of human lassa virus infection with robust acute T-cell activation and long-term virus-specific T-cell responses. J. Infect. Dis. J. Infect. Dis. 215, 1862\u20131872 (2017).","journal-title":"J. Infect. Dis. J. Infect. Dis."},{"key":"72205_CR16","doi-asserted-by":"publisher","first-page":"4719","DOI":"10.1073\/pnas.1502619112","volume":"14","author":"AK Mcelroy","year":"2015","unstructured":"Mcelroy, A. K. et al. Human Ebola virus infection results in substantial immune activation. Proc. Natl. Acad. Sci. USA 14, 4719\u20134724 (2015).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"72205_CR17","doi-asserted-by":"publisher","first-page":"11259","DOI":"10.1128\/JVI.01424-16","volume":"90","author":"A Chandele","year":"2016","unstructured":"Chandele, A. et al. Characterization of human CD8 T cell responses in dengue virus-infected patients from India. J. Virol. 90, 11259\u201311278 (2016).","journal-title":"J. Virol."},{"key":"72205_CR18","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1016\/j.immuni.2008.02.020","volume":"28","author":"JD Miller","year":"2008","unstructured":"Miller, J. D. et al. Human effector and memory CD8+ T cell responses to smallpox and yellow fever vaccines. Immunity 28, 710\u2013722 (2008).","journal-title":"Immunity"},{"key":"72205_CR19","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1004622","author":"K Blom","year":"2015","unstructured":"Blom, K. et al. Specificity and dynamics of effector and memory CD8 T cell responses in human tick-borne encephalitis virus infection. PLos Pathog https:\/\/doi.org\/10.1371\/journal.ppat.1004622 (2015).","journal-title":"PLos Pathog"},{"key":"72205_CR20","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.06075-11","author":"J Wrammert","year":"2012","unstructured":"Wrammert, J. et al. Rapid and massive virus-specific plasmablast responses during acute dengue virus infection in humans. J. Virol . https:\/\/doi.org\/10.1128\/JVI.06075-11 (2012).","journal-title":"J. Virol ."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-72205-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-72205-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-72205-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T18:50:08Z","timestamp":1670352608000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-72205-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,17]]},"references-count":20,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["72205"],"URL":"https:\/\/doi.org\/10.1038\/s41598-020-72205-1","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,17]]},"assertion":[{"value":"14 May 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 August 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 September 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"15306"}}